References
  1. Zhou ES, Bhatia SK. Decrease in Reported Rates of Cardiovascular Device-Related Adverse Events During the Coronavirus Disease 2019 Pandemic. Am J Cardiol. 2022; 163:140-142.
  2. Zhou ES, Bhatia SK. Divergent Effects of COVID-19 Pandemic on Reported Adverse Events for Percutaneous Aortic Valve Prostheses and Non–Allograft Tissue Valves. Am J Cardiol. 2022: S0002-9149(21)01207-8. Online ahead of print.
  3. Food and Drug Administration. MAUDE – Manufacturer and User Facility Device Experience. 2021. Available at:https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/Search.cfm?smc=1. Accessed September 27, 2021.
  4. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed2020;91(1):157-160.
  5. Ueberham L, König S, Pellissier V, Hohenstein S, Meier-Hellmann A, Kuhlen R, Hindricks G, Bollmann A. Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic-insights from the German-wide Helios hospital network. Eur Heart J Qual Care Clin Outcomes. 2021 May 3;7(3):257-264.
  6. Holt A, Gislason GH, Schou M, Zareini B, Biering-Sørensen T, Phelps M, Kragholm K, Andersson C, Fosbøl EL, Hansen ML, Gerds TA, Køber L, Torp-Pedersen C, Lamberts M. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J. 2020 Jun 1;41(32):3072-3079.
  7. Myrda K, Błachut A, Buchta P, Skrzypek M, Wnuk-Wojnar AM, Hoffmann A, Nowak S, Kowalski O, Pruszkowska P, Sokal A, Wita K, Mizia-Stec K, Gąsior M, Kalarus Z. Clinical characteristics of patients with atrial fibrillation or atrial flutter hospitalized during the COVID-19 pandemic: a population analysis of nearly 5 million people. Pol Arch Intern Med. 2021 Jun 29;131(6):574-577.
  8. Myrda K, Błachut A, Buchta P, Skrzypek M, Wnuk-Wojnar AM, Hoffmann A, Nowak S, Kowalski O, Pruszkowska P, Sokal A, Wita K, Mizia-Stec K, Gąsior M, Kalarus Z. Impact of the coronavirus disease 2019 pandemic on atrial fibrillation and atrial flutter ablation rates. The analysis of nearly 5 million Polish population. Kardiol Pol. 2021;79(6):687-689.
  9. Boriani G, Palmisano P, Guerra F, Bertini M, Zanotto G, Lavalle C, Notarstefano P, Accogli M, Bisignani G, Forleo GB, Landolina M, D’Onofrio A, Ricci R, De Ponti R; AIAC Ricerca Network Investigators. Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing). Intern Emerg Med. 2020 Nov;15(8):1445-1456.
  10. Cózar León R, Anguera Camós I, Cano Pérez Ó; collaborators of the Spanish Catheter Ablation Registry. Spanish Catheter Ablation Registry. 20th Official Report of the Heart Rhythm Association of the Spanish Society of Cardiology (2020). Rev Esp Cardiol (Engl Ed). 2021 Dec;74(12):1072-1083.
  11. Leyva F, Zegard A, Okafor O, Stegemann B, Ludman P, Qiu T. Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective. Europace. 2021 Jun 7;23(6):928-936.